Beta-blockers are used in chronic open-angle glaucoma and in primary or secondary intraocular hypertension.

Gastric antisecretory treatment when oral administration is not possible.

* Treatment of severe hypercalcemia of malignant origin.

* Treatment of stage III multiple myeloma with at least one bone lesion.

* Palliative treatment of malignant osteolysis with or without hypercalcemia in addition to specific tumor treatment.

* Treatment of Paget's disease.

This medication is for diagnostic use only.

Contrast agent intended for use in:

Explorations with conventional or computed tomography imaging in adults and children: aortography, peripheral, selective, abdominal, coronary arteriography; whole-body opacification; intravenous urography. Local radiological opacifications (arthrography). Opacification of subarachnoid spaces: sacroradiculography, myelography (10 ml vial).

This medication is for diagnostic use only.

Contrast agent intended for use in:

Explorations with conventional or computed tomography imaging in adults and children: aortography, peripheral, selective, abdominal, coronary arteriography; whole-body opacification; intravenous urography. Local radiological opacifications (arthrography). Opacification of subarachnoid spaces: sacroradiculography, myelography (10 ml vial).

This medication is for diagnostic use only.

Contrast agent intended for use in:

Explorations with conventional or computed tomography imaging in adults and children: aortography, peripheral, selective, abdominal, coronary arteriography; whole-body opacification; intravenous urography. Local radiological opacifications (arthrography). Opacification of subarachnoid spaces: sacroradiculography, myelography (10 ml vial).

This medication is for diagnostic use only.

Contrast agent intended for use in:

Explorations with conventional or computed tomography imaging in adults and children: aortography, peripheral, selective, abdominal, coronary arteriography; whole-body opacification; intravenous urography. Local radiological opacifications (arthrography). Opacification of subarachnoid spaces: sacroradiculography, myelography (10 ml vial).

Piroxicam is indicated for the short-term symptomatic treatment of rheumatoid arthritis or ankylosing spondylitis. Due to its tolerance profile (see sections 4.2, 4.3, and 4.4), piroxicam should not be used as a first-line treatment when an NSAID is indicated.

The decision to prescribe a medicine containing piroxicam should be based on the assessment of all risks specific to each patient (see sections 4.3 and 4.4).

Piroxicam is indicated for the short-term symptomatic treatment of rheumatoid arthritis or ankylosing spondylitis. Due to its tolerance profile (see sections 4.2, 4.3, and 4.4), piroxicam should not be used as a first-line treatment when an NSAID is indicated.

The decision to prescribe a medicine containing piroxicam should be based on the assessment of all risks specific to each patient (see sections 4.3 and 4.4).

REMIFENTANIL is indicated as an analgesic agent during the induction and/or maintenance of general anesthesia. REMIFENTANIL is indicated for analgesia in patients aged 18 years and older who are mechanically ventilated in an intensive care unit.